September 25, 2025

GLP-1 RAs Show Lower Risks in Psoriasis

GLP-1 RAs use in psoriasis is associated with lower alcohol and substance abuse risks.

Conexiant

September 11, 2025

Early TAVR Delays Declines in Left Ventricular/Left Atrial Function for Patients With Severe Aortic Stenosis

Early TAVR preserved heart health in asymptomatic severe aortic stenosis, reinforcing benefits of earlier intervention.

Conexiant

September 05, 2025

CT Scans Rival Echo for Aortic Stenosis

CT angiographic imaging shows near-perfect accuracy in detecting valve disease.

Conexiant

September 07, 2025

Can Handheld AI Echo Grade LVDD?

Artificial-intelligence software enables comprehensive diastolic dysfunction assessment comparable to traditional systems.

Conexiant

September 05, 2025

Dr. Jordan Strom Lays the Scene for ASE 2025

As ASE marks its 50th anniversary in Nashville, the meeting will showcase the latest echocardiography research, updated guidelines, the Kalmanson Lecture, and discussions on workforce challenges.

Conexiant

November 14, 2024

AI-Powered Camera Detects Hypertension, Diabetes

An AI-powered high-speed video camera offers quick, no-contact screenings for high blood pressure and diabetes by analyzing blood flow features in face and palm skin, achieving impressive accuracies.

Reuters

November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

December 02, 2024

Can Hidden Fat Predict Alzheimer's Risk?

A study presented at RSNA 2024 demonstrated findings at midlife, decades prior to patients exhibiting early symptoms of Alzheimer's disease related dementia.

Conexiant

May 15, 2024

ACC 2024: Can an App Improve Access to Nonprescription Statins?

A novel web-based application designed to qualify patients with high low-density lipoprotein (LDL) cholesterol for treatment with nonprescription statins may be comparable to physician assessment.

Conexiant